Diagnosis associated with Tau higher than 1200 pg/mL: Insights from the clinical and laboratory practice - Archive ouverte HAL Access content directly
Journal Articles Clinica Chimica Acta Year : 2019

Diagnosis associated with Tau higher than 1200 pg/mL: Insights from the clinical and laboratory practice

, , , (1) , , , , , , , , , , , , ,
1
S. Lehmann
  • Function : Author
C. Paquet
  • Function : Author
C. Malaplate-Armand
  • Function : Author
S. Schraen
  • Function : Author
M. Quillard-Muraine
  • Function : Author
O. Bousiges
  • Function : Author
C. Delaby
  • Function : Author
J. Dumurgier
  • Function : Author
J. Hugon
  • Function : Author
B. Sablonnière
  • Function : Author
F. Blanc
  • Function : Author
D. Wallon
  • Function : Author
A. Gabelle
  • Function : Author
J.L. Laplanche
  • Function : Author
E. Bouaziz-Amar
  • Function : Author
K. Peoc'H
  • Function : Author

Abstract

Cerebrospinal fluid (CSF) biomarkers are valuable tools for the diagnosis of neurological diseases. We aimed to investigate within a retrospective multicentric study the final diagnosis associated with very high CSF Tau levels and to identify patterns of biomarkers that would differentiate them in clinical practice, to help clinical biologists into physicians' counseling.

Dates and versions

hal-03630157 , version 1 (04-04-2022)

Identifiers

Cite

S. Lehmann, C. Paquet, C. Malaplate-Armand, E. Magnin, S. Schraen, et al.. Diagnosis associated with Tau higher than 1200 pg/mL: Insights from the clinical and laboratory practice. Clinica Chimica Acta, 2019, 495, pp.451-456. ⟨10.1016/j.cca.2019.04.081⟩. ⟨hal-03630157⟩

Collections

UNIV-FCOMTE
9 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More